pharmaphorum
NOVEMBER 28, 2021
The three-year phase 2 trial will be carried out by researchers at Leeds University led by professor of clinical oncology and neuro-oncology Susan Short, and see if adding Sativex (nabiximols) to standard chemotherapy for recurrent glioblastoma can extend survival. Jazz acquired rights to Sativex when it completed its $7.2
pharmaphorum
MARCH 25, 2022
If trials are successful, nabiximols could become one of the first additions to treatment for glioblastoma patients since temozolomide chemotherapy in 2007.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
NOVEMBER 29, 2022
Those immunologically cold gastrointestinal tumours present a real clinical challenge, with a standard of care heavily relying on chemotherapy approaches. Prior to his position at NIT, Dr Yang was Genexine’s Head of Research Institute and Business Division from 2007 to 2014 and has served as a BOD member of Genexine.
The Thyroid Pharmacist
SEPTEMBER 20, 2024
Tegaserod : This medication was approved for IBS-C in 2002, but removed from the market in 2007 due to an increased risk of cardiovascular events. 2007-0606 [13] Adlercreutz H, Järvenpää P. Chemotherapy-Induced Constipation and Diarrhea: Pathophysiology, Current and Emerging Treatments. J Clin Endocrinol Metab. doi:10.1210/jc.2007-0606
European Pharmaceutical Review
DECEMBER 12, 2023
IPH5201 is being investigated in a Phase II trial, MATISSE, in combination with durvalumab (anti-PD-L1) and chemotherapy, in patients with resectable early-stage NSCLC. In 2007, he became in charge for business development and in 2017, also became responsible of the portfolio strategy.
PharmaShots
MARCH 29, 2023
It is the only drug in its class of chemotherapy and is developed from the natural substance found in a sea sponge. Halaven binds to the tumor, blocks cell division, and causes cell death. During 1st cycle of treatment, Halaven is injected as an infusion over a short period of 2-5 mins once a week for two weeks and skipped for one week.
Pharmaceutical Technology
JULY 23, 2008
Demand for treatment The American Cancer Society estimates that over 12 million new cancer cases were diagnosed worldwide in 2007. And are we getting any closer to beating the Big C? All those people need treatment, which creates demand for drugs and stimulates growth in the sector.
Expert insights. Personalized for you.
136 
Let's personalize your content